Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

Publisher： Karger

E-ISSN： 1423-0259|49|4|205-208

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.49, Iss.4, 2013-01, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia

By  

Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite

The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations

By Sallo Ferenc B.   Leung Irene   Mathenge Wanjiku   Kyari Fatima   Kuper Hannah   Gilbert Clare E.   Bird Alan C.   Peto Tunde  

Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization

By  

Case Reports in Ophthalmology, Vol. 5, Iss. 3, 2014-11 ,pp. : 352-356

Karger

Access to resources Recommend Favorite

Agreement between Time-Domain and Spectral-Domain Optical Coherence Tomography in the Assessment of Macular Thickness in Patients with Idiopathic Macular Telangiectasia Type 2

By  

Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. : 144-150

Karger

Access to resources Recommend Favorite

How Prevalent is Macular Telangiectasia Type 2?

By Chew Emily Y.  

Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. : 183-184

Informa Healthcare

Access to resources Recommend Favorite